On Wednesday, CrowdStrike announced an expansion of its partnership with Alphabet Inc 's GOOG +0.73% Get Free Report Google Cloud to enable end-to-end security for AI innovation with the company's ...

Vertex Pharmaceuticals (NASDAQ: VRTX) is a great example of biotech success. It recently won approval for a non-opioid pain ...

Vertex Pharmaceuticals slipped 1.41% to close at $475.49, managing to outperform a much gloomier market where the S&P 500 nose-dived 3.46%. Despite the drop, Vertex flexed its resilience, outpacing ...

Vertex Pharmaceuticals (VRTX) reachead $475.49 at the closing of the latest trading day, reflecting a -1.41% change compared to its last close.

GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...

US Stock Market on March 12: The Dow Jones Industrial Average, the S&P 500 and the Nasdaq Composite indices eked out mild gains amid choppy trade on Wednesday, in some respite for Wall Street bulls ...

The recent Board changes at The Trade Desk (NasdaqGM:TTD) include the upcoming resignation of board member David Wells, and the appointment of Will Platt-Higgins as Executive Vice President of ...

CEO Sundar Pichai delivered a keynote speech at the Google Cloud Next (LON:NXT) 2025 conference, where he highlighted the tech giant’s commitment to organizing the world’s information and making it ...

The blue-chip Dow Jones was cautiously higher at the opening bell on Wednesday as Donald Trump's tit-for-tat tariff war with ...

Equity markets may be struggling because of President Donald Trump's current economic policies, but that doesn't mean ...

Shares in major U.S. and European pharmaceutical companies fell sharply Wednesday, underperforming a broader market downturn, after U.S. President Donald Trump said the country would soon impose “a ...

Morgan Stanley analyst Terence Flynn maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...